Pharmacogenetics of smoking cessation in general practice: results from the patch II and patch in practice trials.

David, Sean P; Johnstone, Elaine C; Churchman, Michael; Aveyard, Paul; Murphy, Michael F G; Munafò, Marcus R

David, Sean P; Johnstone, Elaine C; Churchman, Michael; Aveyard, Paul; Murphy, Michael F G; Munafò, Marcus R.

Affiliation

David SP; Center for Education and Research in Family and Community Medicine, 1215 Welch Road, Modular G, Stanford University School of Medicine, Stanford, CA 94305, USA. spdavid@stanford.edu

Nicotine Tob Res ; 13(3): 157-67, 2011 Mar.

Article in En | MEDLINE | ID: mdl-21330274

Subject(s)

Pharmacogenetics; Smoking Cessation/methods; Smoking/drug therapy; Genotype; Humans; Nicotine/administration & dosage; Nicotine/therapeutic use; Polymorphism, Genetic/genetics; Randomized Controlled Trials as Topic; Smoking/genetics

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Database: MEDLINE Main subject: Pharmacogenetics / Smoking / Smoking Cessation Type of study: Clinical_trials / Guideline Limits: Humans Language: En Journal: Nicotine Tob Res Journal subject: SAUDE PUBLICA Year: 2011 Type: Article Affiliation country: United States

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google